Stephen P. MacMillan currently works at Hologic, Inc., as Chairman, President & Chief Executive Officer from 2015, Illumina, Inc., as Non-Executive Chairman from 2023, and Advanced Medical Technology Association, as Director. Mr. MacMillan also formerly worked at Stryker Corp., as Chairman, President & Chief Executive Officer from 2010 to 2012, Sbiomed LLC, as Chief Executive Officer from 2012 to 2013, Texas Instruments Incorporated, as Independent Director from 2011 to 2012, Boston Scientific Corp., as Independent Director from 2015 to 2021, Alere, Inc., as Director in 2013, Domain Surgical, Inc., as Director, Southwest Michigan First (Venture Capital), as Director, United Way of The Battle Creek & Kalamazoo Region, as Director, Pharmacia Corp., as Sector Vice President-Global Specialty Operations from 1999 to 2003, Johnson & Johnson-Merck Consumer Pharmaceuticals Co., as President from 1989 to 1999, and Davidson College, as Trustee. Mr. MacMillan received his undergraduate degree from Davidson College.
Robert S. Epstein
Robert S. Epstein founded Epstein Health LLC in 2012, where he is working as Chairman & Chief Executive Officer from 2012. Dr. Epstein also currently works at Veracyte, Inc., as Chairman, Illumina, Inc., as Independent Director from 2012, Fate Therapeutics, Inc., as Independent Director from 2014, Tasso, Inc., as Director, Intellos Health LLC, as Director, and Biologics & Biosimilars Collective Intelligence Consortium, as Managing Director from 2017. Dr. Epstein also formerly worked at Veracyte SD, Inc., as Chairman from 2019 to 2021, Proteus Digital Health, Inc., as Director from 2013 to 2020, AVEO Pharmaceuticals, Inc., as Independent Director in 2014, Drug Information Association, as Director, On-Q-ity, Inc., as Director from 2010 to 2014, International Society for Quality of Life Research, as Director, Mindstrong, Inc., as Director, Medco Health Solutions, Inc., as Chief Research & Development Officer from 2010 to 2012, Medco Research Institute LLC, as President from 2010 to 2012, Health Outcomes Research Europe SL, as President, and International Society for Pharmacoeconomics & Outcomes Rsch, as President from 1998 to 1999. Dr. Epstein received his graduate degree from the University of Maryland and undergraduate degree and doctorate degree from the University of Michigan.
Frances Hamilton Arnold
Frances Hamilton Arnold is the founder of Gevo, Inc. (2005), Aralez, Inc. (2019), and Provivi, Inc. (2014) where the title held is Director. Dr. Arnold is currently Co-Chairman at President's Council of Advisors on Science & Technology, Vice Chairman at Gordon Research Conferences, Independent Director at Illumina, Inc. (since 2016), Director & Professor at California Institute of Technology (since 1986), Independent Director at Alphabet, Inc. (since 2019), Director at Donna & Benjamin M Rosen Bioengineering Center, Director at National Resilience, Inc. (since 2020), Director at Generate Biomedicines, Inc. (since 2019), Director at Altos Labs, Inc., Board of Advisor at Angeleno Group LLC, Member at American Academy of Arts & Sciences, Member at National Academy of Engineering, Member at National Academy of Medicine (United States), Member at The National Academies of Science, and Venture Partner at Catalio Capital Management LP. Education includes an undergraduate degree from Princeton University (1979) and a doctorate from the University of California, Berkeley (1985).
Philip W. Schiller
Philip W. Schiller is an Independent Director at Illumina, Inc. and a Trustee at Bowdoin College. He was previously the Director-Product Marketing at FirePower Systems, Inc., Senior Vice President-Worldwide Marketing at Apple, Inc., Vice President-Product Marketing at Macromedia, Inc., and a Trustee at Boston College. He also worked as a Manager-Information Technology at Nolan, Norton & Co. BV. Schiller received his undergraduate degree from Boston College in 1982.
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
Caroline D. Dorsa
Caroline D. Dorsa founded Institute For Advanced Clinical Trials For Children in 2016, where she is working as Director Emeritus from 2016. Ms. Dorsa also currently works at Biogen, Inc., as Chairman from 2023, Illumina, Inc., as Independent Director from 2017, Duke Energy Corp., as Independent Director from 2021, and various other companies. Ms. Dorsa also formerly worked at PSEG Power LLC, as Chief Financial Officer, Director & Executive VP from 2014 to 2015, Biogen Idec New Ventures, Inc., as Director, The Newark Museum of Art, as Director, and various other companies. Ms. Dorsa received her undergraduate degree from Colgate University and Masters Business Admin degree from Columbia Business School.
Gary S. Guthart
Gary S. Guthart currently works at Intuitive Surgical, Inc., as Chief Executive Officer & Director from 2023, Illumina, Inc., as Independent Director from 2017, and Silicon Valley Leadership Group, as Director from 2020. Dr. Guthart also formerly worked at Affymetrix, Inc., as Independent Director from 2009 to 2016, National Aeronautics & Space Administration, as Member-Human Factors Research Lab, and Tidal Software, Inc., as Vice President. Dr. Guthart received his graduate degree and doctorate degree from California Institute of Technology and undergraduate degree from the University of California, Berkeley.
Susan E. Siegel
Susan E. Siegel is the founder of Stanford Health Care. She currently holds the position of Chairman & Board of Director at The Engine Accelerator, Inc. and Co-Chairman at Stanford Medicine. Additionally, she serves as an Independent Director at Illumina, Inc., Align Technology, Inc., the University of California, Berkeley, The Tech Interactive, RAND Health, Nevro Corp., National Center for Advancing Translational Sciences, Kaiser Family Foundation, Center for Strategic & International Studies, Inc., The National Academies of Science, Women Corporate Directors, and the University of California. She is also a Council Member-Biotechnology Research at the Center for Strategic & International Studies, Inc. and a Member-Presidents Council at The National Academies of Science. In her former positions, Ms. Siegel served as the Chief Innovation Officer & CEO-Business Innovations at GE Aerospace. She was also the President & Director at Affymetrix, Inc., an Independent Director at Pacific Biosciences of California, Inc., and a Director at Crescendo Bioscience LLC, Cellective Dx Corp., RainDance Technologies, Inc., Medtronic Monitoring, Inc., Analyte Health, Inc., DVS Sciences, Inc., The Brigham & Women's Hospital, Inc., and the University of California, Berkeley. She held the position of Director-Baker Bioenginuity Hub at the University of California, Berkeley. Additionally, she served as a Director at National Venture Capital Association, Life Technologies Clinical Services Lab, Inc., On-Q-ity, Inc., Silicon Valley Technical Institute, Bio-Rad Laboratories, Inc., EIDP, Inc., and Global Life Sciences Solutions USA LLC. She was the Chief Innovation Officer at GE Ventures LLC and a Partner at MDV Management Co. LLC. She also served as the President of Hoefer Pharmacia Biotech, Inc.Ms. Siegel completed her undergraduate studies at the University of Puerto Rico and her graduate studies at Boston University School of Medicine.
Scott Gottlieb
Scott Gottlieb is currently an Independent Director at Pfizer Inc., Illumina, Inc., The Mount Sinai Medical Center, Inc., Tempus AI, Inc., Aetion, Inc., National Resilience, Inc., and NEA Management Co. LLC. He is also a Member of the National Academy of Medicine (United States). Previously, he served as an Independent Director at CombiMatrix Corp., Managing Director at T.R. Winston & Co., Inc., Independent Member of the Board of Directors at Bravo Health, Inc., Member of the Board of Directors at MedAvante, Inc., Independent Member of the Board of Directors at Molecular Insight Pharmaceuticals, Inc., and Independent Member of the Board of Directors at American Pathology Partners, Inc. He also held positions at Aseko, Inc., Targeted Medical Pharma, Inc., EMI Holding, Inc., Gradalis, Inc., Tolero Pharmaceuticals, Inc., Daiichi Sankyo, Inc., and Aptiv Solutions, Inc. Additionally, he worked as an Analyst at Alex. Brown & Sons, Inc. and as a Senior Adviser to the Administrator at the Centers for Medicare & Medicaid Services (US). He served as the Deputy Commissioner-Medical & Scientific Affairs at the US Food & Drug Administration from 2005 to 2007 and as the Commissioner from 2017 to 2019. Dr. Gottlieb received his undergraduate degree from Wesleyan University and his doctorate from the Icahn School of Medicine at Mount Sinai.
Scott B. Ullem
Scott B. Ullem currently works at Illumina, Inc., as Independent Director from 2023, Egnite, Inc., as Director, Edwards Lifesciences Corp., as Chief Financial Officer & Vice President from 2014, and Edwards Lifesciences Foundation, as Chief Financial Officer from 2014. Mr. Ullem also formerly worked at Bank of America Corp., as Managing Director, Berry Global Group, Inc., as Independent Director from 2016 to 2024, Banc of America Securities LLC, as Managing Director in 2008, The Aspen Institute, Inc., as Director, Berry Global, Inc., as Director, Bemis Co., Inc., as Chief Financial Officer & Vice President from 2010 to 2013, CAS Medical Systems, Inc., as Chief Financial Officer & Vice President, and Goldman Sachs & Co. LLC, as MD-Investment Banking Services Group. Mr. Ullem received his undergraduate degree from DePauw University and Masters Business Admin degree from Harvard Business School.
Jacob Thaysen
Jacob Thaysen is the founder of Cantion A. He is currently the Chief Executive Officer & Director at Illumina, Inc. and also serves as a Director at Lasergen, Inc. Previously, he was the SVP & President-Life Sciences & Applied Markets at Agilent Technologies, Inc. from 2018 to 2023. He also held positions as a Director at Gen9, Inc., Vice President-Research & Development at Cytologix Corp., and Vice President-System Development, R&D at Dako Denmark ApS. Thaysen received his graduate and doctorate degrees from the Technical University of Denmark.
Anna S. Richo
Anna S. Richo is currently a Director at Exelon Corp., Twin Cities Diversity in Practice, Illumina, Inc., Children's Health Care, Cargill Foundation, and DePaul University. She previously worked as a Director at Cytyc Corp., an Independent Director at Adamas Pharmaceuticals LLC, a Vice President at Baxter Healthcare Corp., an Attorney at The NutraSweet Co., the Chief Compliance Officer & SVP at Amgen Ventures LLC, an Associate at Peterson & Ross, the Chief Compliance Officer & Senior Vice President at Amgen, Inc., and the Executive Vice President & General Counsel at UCB SA. Ms. Richo received her undergraduate degree from Cornell University and her graduate degree from DePaul University College of Law.